Factors influencing the lipid response to selective alpha 1-inhibition.
Dzau
V J
VJ
Department of Medicine, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts 02115.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000818:Animals; D002784:Cholesterol / Q000378:metabolism; D002791:Cholesterol, Dietary / Q000008:administration & dosage; D004032:Diet; D017292:Doxazosin; D006801:Humans; D006973:Hypertension / Q000378:metabolism / Q000503:physiopathology; D050356:Lipid Metabolism; D008071:Lipoprotein Lipase / Q000378:metabolism; D008077:Lipoproteins, LDL / Q000378:metabolism; D009752:Nutritional Status; D011224:Prazosin / Q000031:analogs & derivatives / Q000494:pharmacology; D013045:Species Specificity
D000317:Adrenergic alpha-Antagonists; D002791:Cholesterol, Dietary; D008077:Lipoproteins, LDL; D002784:Cholesterol; D008071:Lipoprotein Lipase; D017292:Doxazosin; D011224:Prazosin